Laurent Dassonneville

发表

Distribution of furamidine analogues in tumor cells: targeting of the nucleus or mitochondria depending on the amidine substitution.

C. Bailly, W. Wilson, Arvind Kumar, 2002, Cancer research.

Distribution of furamidine analogues in tumor cells: influence of the number of positive charges.

C. Bailly, W. Wilson, Arvind Kumar, 2002, Journal of medicinal chemistry.

Hydroxyurea-induced apoptosis in an EBV-immortalized lymphoblastoid cell line.

C. Bailly, P. Fenaux, Laurent Dassonneville, 2004, Oncology research.

Cytotoxicity and cell cycle effects of the plant alkaloids cryptolepine and neocryptolepine: relation to drug-induced apoptosis.

C. Bailly, L. Pieters, A. Lansiaux, 2000, European journal of pharmacology.

The DNA intercalating alkaloid cryptolepine interferes with topoisomerase II and inhibits primarily DNA synthesis in B16 melanoma cells.

L. Angenot, C. Bailly, P. Colson, 1998, Biochemistry.

Binding of Hoechst 33258 to the TAR RNA of HIV-1. Recognition of a pyrimidine bulge-dependent structure.

C. Bailly, P. Colson, C. Houssier, 1997, Nucleic acids research.

Homocamptothecin, an E-ring-modified camptothecin analogue, generates new topoisomerase I-mediated DNA breaks.

C. Bailly, A. Lansiaux, D. Bigg, 1999, Biochemistry.

Inhibition of topoisomerase II by the marine alkaloid ascididemin and induction of apoptosis in leukemia cells.

C. Bailly, B. Banaigs, B. Baldeyrou, 2000, Biochemical pharmacology.

Homocamptothecin, an E-ring modified camptothecin with enhanced lactone stability, retains topoisomerase I-targeted activity and antitumor properties.

R. Kiss, C. Bailly, P. Kasprzyk, 1999, Cancer research.